Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

522
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
522
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

155
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
155
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Long-term Potentiation01:25

Long-term Potentiation

2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
2.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

218
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EFFECT OF CHRONIC ADMINISTRATION OF LOW DOSES OF POLYPEPTIDES OF CATTLE CEREBRAL CORTEX AND METHIONYL-GLUTAMYL-HISTIDYL-PHENYLALANYL-PROLYL-GLYCYL-PROLINE ON BEHAVIORAL RESPONSES OF RAT OFFSPRING.

Georgian medical news·2024
Same author

SPECIFICS OF PRESCRIBING ANTIRETROVIRAL DRUGS IN THE TREATMENT OF HIV INFECTION.

Georgian medical news·2024
Same author

EFFECT OF SOME IMMUNOMODULATORY DRUGS ON EMBRYONIC DEVELOPMENT OF DANIO RERIO FISH.

Georgian medical news·2024
Same author

COMPARATIVE ANALYSIS OF THE EFFECTS OF SOME HEPATOPROTECTORS IN EXPERIMENTALLY INDUCED MAFLD IN ADULT WISTAR RATS.

Georgian medical news·2024
Same author

INFLUENCE OF PROFICIENCY OF SYNTHETIC FOLIC ACID ON THE NEUROLOGICAL SYMPTOMS OF RATS.

Georgian medical news·2023
Same author

A COMPARATIVE REVIEW OF THE USE OF DANIO RERIO (ZEBRAFISH) AS A MODEL OBJECT IN PRECLINICAL STUDIES.

Georgian medical news·2023
Same journal

NON-PHARMACOLOGICAL INTERVENTIONS FOR RESTLESS LEG SYNDROME IN HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.

Georgian medical news·2026
Same journal

CLINICAL RESULTS OF DELORME'S AND ALTEMEIER'S PROCEDURES IN RECTAL PROLAPSE.

Georgian medical news·2026
Same journal

EVALUATION OF GEORGIAN MEDICAL DOCTORS' RESEARCH EXPERIENCE AND PERCEPTIONS TOWARD COLLABORATIVE RESEARCH WITH UNIVERSITIES.

Georgian medical news·2026
Same journal

PSYCHOLOGICAL ASPECTS OF USING SUGGESTIVE METHODS IN COGNITIVE-BEHAVIORAL THERAPY.

Georgian medical news·2026
Same journal

MORPHOLOGY AND PREVALENCE OF C-SHAPED CANALS IN MANDIBULAR FIRST MOLARS OF AN IRAQI KURDISTAN REGION POPULATION: A CONE-BEAM COMPUTED TOMOGRAPHY ASSESSMENT.

Georgian medical news·2026
Same journal

DERMATOSURGERY ROUNDS: THE DOUBLE ROTATION (YIN-YANG) FLAP AS BASIC WEAPON IN THE FIGHT AGAINST KERATINOCYTE CANCER OF THE SCALP.

Georgian medical news·2026
See all related articles

Related Experiment Video

Updated: Jul 20, 2025

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

8.1K

NEURODEGENERATION AND NMDA.

K Gulyaeva1, M Fokin1, D Kachanov1

  • 1North-Western Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia; S.M. Kirov Military Medical Academy, Saint-Petersburg, Russia; Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russia.

Georgian Medical News
|July 31, 2023
PubMed
Summary
This summary is machine-generated.

The N-methyl D-aspartate (NMDA) receptor is crucial for brain functions like memory. Its decline with age and certain drug use impacts brain health, highlighting the need for understanding its role in neurodegenerative diseases.

More Related Videos

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

9.3K
A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

7.7K

Related Experiment Videos

Last Updated: Jul 20, 2025

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

8.1K
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

9.3K
A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

7.7K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The N-methyl D-aspartate (NMDA) receptor is a key player in human brain function, particularly in areas like the hippocampus and cortex.
  • Its effective functioning is vital for associative memory, learning, and maintaining synaptic density.

Purpose of the Study:

  • To explore the distribution and functional significance of NMDA receptors in the brain.
  • To investigate the impact of aging and pharmaceutical interventions on NMDA receptor quantity and structure.
  • To understand the therapeutic potential and limitations of NMDA receptor antagonists in neurological conditions.

Main Methods:

  • Radioligand analysis was employed to determine the density and distribution of NMDA receptors.
  • Literature review of studies examining age-related changes and the effects of antidepressants and antagonists on NMDA receptors.

Main Results:

  • Highest NMDA receptor density is observed in the hippocampus, striatum, cortex, and amygdala.
  • Aging and the use of selective serotonin reuptake inhibitors (SSRIs) are associated with a decrease in NMDA receptor number and altered morphology.
  • NMDA receptor antagonists like memantine show potential in managing Alzheimer's disease symptoms, while ketamine's use is limited by side effects.

Conclusions:

  • Understanding NMDA receptor composition, signaling, and age-related changes is crucial for preventing neurodegenerative diseases.
  • NMDA receptor function is directly linked to cognitive processes and is susceptible to various physiological and pharmacological influences.